Comments on: Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers

Comments on: Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers https://dewpointx.com/dewpoint-therapeutics-announces-dptx3496-as-a-development-candidate-for-the-treatment-of-colorectal-breast-and-lung-cancers/ The Biomolecular Condensates Company Wed, 29 Jan 2025 13:01:38 +0000 hourly 1